Use of recombinant factor VIIa (rFVIIa) to control intraoperative bleeding in pediatric brain tumor patients

Pediatric Blood and Cancer

Volumn 43, Issue 6, 2004, Pages 703-705

  Heisel, Margaret ^a   Nagib, M ^a   Madsen, L ^a   Alshiekh, M ^a   Bendel, A ^a  

^a CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

Author keywords

Pediatric; Recombinant factor VIIa; RFVIIa; Surgical hemostasis

Indexed keywords

FIBRINOGEN; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ARTICLE; BLEEDING; BRAIN TUMOR; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CRANIOTOMY; FEMALE; HEMOSTASIS; HUMAN; HYDROCEPHALUS; INFANT; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

ADOLESCENT; BLOOD LOSS, SURGICAL; BLOOD VOLUME; BRAIN NEOPLASMS; CHILD, PRESCHOOL; FACTOR VII; FEMALE; HUMANS; RECOMBINANT PROTEINS;

EID: 6944235839     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20144     Document Type: Article

References (15)

1. Bleyer WA. Epidemiologic impact of children with brain tumors. Childs Nerv Syst 1999;15:758-763.
2. Gurney JG, Wall DA, Jukich PJ, et al. The contribution of nonmalignant tumors to CNS tumor incidence rates among children in the United States. Cancer Causes Control 1999;10:101-105.
3. Lusher J, Ingerslev J, Roberts H, et al. Clinical experience with recombinant factor VIIa. Blood Coagul Fibrinolysis 1998;9:119-128.
4. Martinowitz U, Kenet G, Segal E, et al. Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma 2001;51:438-439.
5. Aldouri M. The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients. Pathophysiol Haemost Thromb 2002;32(Suppl 1):41-46.
6. Poon M, Demers C, Jobin F, et al. Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia. Blood 1999;94:3951-3953.
7. Hunault M, Bauer KA. Recombinant factor VIIa for the treatment of congenital factor VII deficiency. Semin Thromb Hemost 2000;26:401-405.
8. Kleinman MB. Anti-inhibitor coagulant complex for the rescue therapy of acquired inhibitors to factor VIII: Case report and review of the literature. Haemophilia 2002;8:694-697.
9. Chuansumrit A, Chantarojanasiri T, Isarangkura P, et al. Recombinant activated factor VII in children with acute bleeding resulting from liver failure and disseminated intravascular coagulation. Blood Coagul Fibrinolysis 2000;11(Suppl 1):S101-S105.
10. Jurlander B, Thim L, Klausen N, et al. Recombinant activated factor VII (rFVIIa): Characterization, manufacturing, and clinical development. Semin Thromb Hemost 2001;27:373-383.
11. Poon MC, d'Oiron R. Recombinant activated factor VII (Novo Seven) treatment of platelet-related bleeding disorders. International Registry on Recombinant Factor VIIa and Congenital Platelet Disorders Group. Blood Coagul Fibrinolysis 2000;11(Suppl 1):S55-S68.
12. Poon MC. Use of recombinant factor VIIa in hereditary bleeding disorders. Curr Opin Hematol 2001;8:312-318.
13. Meijer K, Hendriks HG, De Wolf JT, et al. Recombinant factor VIIa in orthotopic liver transplantation: Influence on parameters of coagulation and fibrinolysis. Blood Coagul Fibrinolysis 2003;14:169-174.
14. Hendriks HG, Van der Maaten JM, de Wolf J, et al. An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII. Anesth Analg 2001;93:287-289.
15. Gerlach R, Marquardt G, Wissing H, et al. Application of recombinant factor VII during surgery for a giant skull base hemangiopericytoma to achieve safe hemostasis. J Neurosurg 2002;96:946-948.